William A Eaton

14PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyHaematologyCardiovascular medicine and haematology not elsewhere classifiedClinical pharmacology and therapeuticsCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease.

Anna Conrey, Nancy Asomaning, Ingrid Frey

|Oct 28, 2025
Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model.

Henna Butt, Shruti Sathish, Evan London

|Nov 06, 2024
Therapeutic potential of the latest oxygen affinity-modifying agent, GBT021601, for treating sickle cell disease is questionable.

Braydon Alaimo, Belhu Metaferia, Troy Cellmer

|Jan 05, 2024
In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation.

Alexis K Leonard, Dana Furstenau, Zaina Inam

|Dec 20, 2023
Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.

Dina S Parekh, William A Eaton, Swee Lay Thein

|Nov 15, 2022
A retrospective on statistical mechanical models for hemoglobin allostery.

William A Eaton

Pageof 3

Frequent Collaborators

6 joint publications

Swee Lay Thein

2 joint publications

Emily B Dunkelberger

2 joint publications

Roland R Netz

2 joint publications

Julia Z Xu